Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Covington
Boehringer Ingelheim
Fish and Richardson
AstraZeneca
Chinese Patent Office
Johnson and Johnson
Deloitte
US Department of Justice

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 091681

« Back to Dashboard

NDA 091681 describes DISULFIRAM , which is a drug marketed by Alvogen Malta and is included in one NDA. It is available from seven suppliers. Additional details are available on the DISULFIRAM profile page.

The generic ingredient in DISULFIRAM is disulfiram. There are seven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the disulfiram profile page.
Summary for 091681
Tradename:DISULFIRAM
Applicant:Alvogen Malta
Ingredient:disulfiram
Patents:0
Therapeutic Class:Antidotes, Deterrents, and Toxicologic Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 091681
Medical Subject Heading (MeSH) Categories for 091681
Suppliers and Packaging for NDA: 091681
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DISULFIRAM disulfiram TABLET;ORAL 091681 ANDA Alvogen Inc. 47781-607 N 47781-607-30
DISULFIRAM disulfiram TABLET;ORAL 091681 ANDA Alvogen Inc. 47781-607 N 47781-607-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength250MG
Approval Date:Aug 8, 2013TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Healthtrust
UBS
Farmers Insurance
Boehringer Ingelheim
Queensland Health
McKinsey
McKesson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.